A multicenter, multicohort, phase 2 study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer - Trial in progress

Saved in:
Bibliographic Details
Published inAnnals of Oncology Vol. 29; p. v83
Main Authors T. Yoshino, S. Siena, R. Dalal, Y. Okuda, E. Yamamoto, A. Grothey
Format Journal Article
LanguageJapanese
Published Elsevier BV 01.06.2018
Subjects
Hematology
Oncology
Online AccessGet full text
ISSN0923-7534
DOI10.1093/annonc/mdy151.294

Cover

More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdy151.294